Stock Rich List
#182 on the corporate holders of 809 holders

Atlas Venture Associates Opportunity I, L.P.

10% owner at Kymera Therapeutics; 10% owner at Disc Medicine; 10% owner at Xilio Therapeutics.

$932M
in disclosed stock, −$15.3M (−1.61%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
182nd of 809
Companies held
3
Largest holding
KYMR, 81.6% of total
Latest SEC filing
Jan 12, 2024
Listed but not counted
$122M

What the $932M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Kymera Therapeutics KYMR
Common Stock
Directly5,365,563$119.39$641M68.7%Form 4, Nov 3, 2022
Kymera Therapeutics KYMR
Common Stock
Indirectly (see filing footnote)1,001,417$119.39$120M12.8%Form 4, Nov 3, 2022
Disc Medicine IRON
Common Stock
Directly1,449,686$76.11$110M11.8%Form 4, Jan 10, 2024
Disc Medicine IRON
Common Stock
Indirectly (see filing footnote)786,160$76.11$59.8M6.4%Form 4, Jan 10, 2024
Xilio Therapeutics XLO
Common Stock
Directly144,307
split-adjusted
$7.51$1.1M0.1%Form 4, Jan 12, 2024
Xilio Therapeutics XLO
Common Stock
Indirectly (see filing footnote)52,487
split-adjusted
$7.51$394K0.0%Form 4, Jan 12, 2024

Share counts are the amounts Atlas Venture Associates Opportunity I, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Atlas Venture Associates Opportunity I, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Kymera Therapeutics KYMR
Common Stock
Through Atlas Venture Opportunity Fund I, L.P.
Held by a company or fund the insider manages
1,022,502$119.39$122M—Form 4, Nov 2, 2022

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
179Energy Holding Corp
10% owner, Tecnoglass Holdings
$957M−$9.2M (−0.95%)
180Adolph Coors CO LLC
10% owner, Molson Coors Beverage
$956M−$23.1M (−2.36%)
181Two Sigma Management, LLC
10% owner, Hamilton Insurance Group
$943M−$13.2M (−1.38%)
182Atlas Venture Associates Opportunity I, L.P.
10% owner, Kymera Therapeutics
$932M−$15.3M (−1.61%)
183Broadwood Capital INC
10% owner, STAAR Surgical
$929M−$10.5M (−1.11%)
184Teacher Retirement System OF Texas
Insider, Life Time Group Holdings
$928M−$22.0M (−2.31%)
185ASP Amentum Investco LP
10% owner, Amentum Holdings
$923M+$4.0M (+0.43%)

Other Kymera Therapeutics insiders

All KYMR insiders

Questions

How much stock does Atlas Venture Associates Opportunity I, L.P. own?

Atlas Venture Associates Opportunity I, L.P. holds $931,801,900 in listed stock based on SEC filings and current prices, mostly Kymera Therapeutics (KYMR). That ranks 182nd on the Stock Rich List.

Is this Atlas Venture Associates Opportunity I, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.